drugset / Trial / NCT00645437
A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function.
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary objective was to evaluate the pharmacokinetics and safety of two dosing regimens of levofloxacin in patients with varying degrees of renal function.
Timeline
- Start
- 2004-10
- Primary completion
- —
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levofloxacin | Small molecule | 250 mg | — |
| Subject | Levofloxacin | Small molecule | 500 mg | — |
| Subject | Levofloxacin | Small molecule | 750 mg | — |